All Blogs

Sep 17, 2019

AlivaMab collaborates with Janssen for antibody discovery; Lundbeck acquires Alder BioPharmaceutical; Helsinn and Mundipharma announce China approval of Akynzeo


Aug 08, 2024

How HR+/ HER2-Breast Cancer Emerging Drugs Will Transform The Market?


Aug 08, 2024

HR+/HER2- Breast Cancer: Unveiling the Worldwide Advances and Strategies


Sep 12, 2019

Genenta Sciences raises USD 14.54M; GSK announces to buy Sitari Pharmaceuticals; Mallinckrodt to Sell BioVectra for USD 25M; Lexicon to receive USD 260M from terminated diabetes partnership 


Sep 11, 2019

Japan is transforming its Healthcare sector through Regenerative Medicine


Sep 10, 2019

Daiichi Sankyo fuels commercialization of DS-8201 in Japan; Roivant Sciences transfers its biotech stake for USD 3 Billion; FDA, EMA accepts marketing of Allergan’s abicipar


Sep 09, 2019

FDA approves Ofev for interstitial lung disease


Aug 08, 2024

Metastatic HER2-Positive Breast Cancer Landscape: What You Need to Know


Sep 05, 2019

Vertex acquires Semma; Luxturna gets approval for rare eye disorder


Sep 04, 2019

Driving factors boosting the Hepatocellular Carcinoma Market